Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan E Alpert

Showing results (81-90 of 136) with videos related to

Pageof 14
Sort By:
The Journal of Clinical Psychiatry|December 9, 2003
Psychiatric comorbidity as a predictor of clinical response to nortriptyline in treatment-resistant major depressive disorderGeorge I Papakostas, Timothy J Petersen, Amy H Farabaugh, et al.
Psychiatry Research|November 22, 2005
Brain MRI white matter hyperintensities and one-carbon cycle metabolism in non-geriatric outpatients with major depressive disorder (Part II)George I Papakostas, Dan V Iosifescu, Perry F Renshaw, et al.
The Journal of Clinical Psychiatry|August 25, 2004
Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 2: predictors of relapse during the continuation phase of pharmacotherapyGeorge I Papakostas, Timothy Petersen, David Mischoulon, et al.
The American Journal of Psychiatry|September 2, 2006
Predictors of relapse in a prospective study of fluoxetine treatment of major depressionPatrick J McGrath, Jonathan W Stewart, Frederic M Quitkin, et al.
Journal of Affective Disorders|October 27, 2022
Examining tradeoffs between cognitive effort and relief among adults with self-injurious behaviorPeter J Franz, Rebecca G Fortgang, Alexander J Millner, et al.
Psychosomatics|March 25, 2010
Cognitive-behavioral therapy for patients with Parkinson's disease and comorbid major depressive disorderAmy Farabaugh, Joseph J Locascio, Liang Yap, et al.
The Journal of Clinical Psychiatry|February 20, 2003
Nortriptyline for treatment-resistant depressionAndrew A Nierenberg, George I Papakostas, Timothy Petersen, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|May 9, 2015
Similar changes in cognitions following cognitive-behavioral therapy or escitalopram for major depressive disorder: Implications for mechanisms of changeAmy Farabaugh, Lauren Fisher, Maren Nyer, et al.
Medical Care|December 1, 2007
Ethnicity/race and outcome in the treatment of depression: results from STAR*DIra M Lesser, Daniel B Castro, Bradley N Gaynes, et al.
The Journal of Clinical Psychiatry|August 26, 2016
The Effectiveness of Telepsychiatry-Based Culturally Sensitive Collaborative Treatment for Depressed Chinese American Immigrants: A Randomized Controlled TrialAlbert Yeung, Max A Martinson, Lee Baer, et al.
Pageof 14

Showing results (81-90 of 136) with videos related to

Sort By:
Pageof 14
The Journal of Clinical Psychiatry|December 9, 2003
Psychiatric comorbidity as a predictor of clinical response to nortriptyline in treatment-resistant major depressive disorderGeorge I Papakostas, Timothy J Petersen, Amy H Farabaugh, et al.
Psychiatry Research|November 22, 2005
Brain MRI white matter hyperintensities and one-carbon cycle metabolism in non-geriatric outpatients with major depressive disorder (Part II)George I Papakostas, Dan V Iosifescu, Perry F Renshaw, et al.
The Journal of Clinical Psychiatry|August 25, 2004
Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 2: predictors of relapse during the continuation phase of pharmacotherapyGeorge I Papakostas, Timothy Petersen, David Mischoulon, et al.
The American Journal of Psychiatry|September 2, 2006
Predictors of relapse in a prospective study of fluoxetine treatment of major depressionPatrick J McGrath, Jonathan W Stewart, Frederic M Quitkin, et al.
Journal of Affective Disorders|October 27, 2022
Examining tradeoffs between cognitive effort and relief among adults with self-injurious behaviorPeter J Franz, Rebecca G Fortgang, Alexander J Millner, et al.
Psychosomatics|March 25, 2010
Cognitive-behavioral therapy for patients with Parkinson's disease and comorbid major depressive disorderAmy Farabaugh, Joseph J Locascio, Liang Yap, et al.
The Journal of Clinical Psychiatry|February 20, 2003
Nortriptyline for treatment-resistant depressionAndrew A Nierenberg, George I Papakostas, Timothy Petersen, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|May 9, 2015
Similar changes in cognitions following cognitive-behavioral therapy or escitalopram for major depressive disorder: Implications for mechanisms of changeAmy Farabaugh, Lauren Fisher, Maren Nyer, et al.
Medical Care|December 1, 2007
Ethnicity/race and outcome in the treatment of depression: results from STAR*DIra M Lesser, Daniel B Castro, Bradley N Gaynes, et al.
The Journal of Clinical Psychiatry|August 26, 2016
The Effectiveness of Telepsychiatry-Based Culturally Sensitive Collaborative Treatment for Depressed Chinese American Immigrants: A Randomized Controlled TrialAlbert Yeung, Max A Martinson, Lee Baer, et al.
Pageof 14